Therapeutic Candidate Services
-
Manufactured by Kura Oncology, Inc.based in USA
Kura Oncology’s clinical trial programs represent the next step toward our goal of realizing the full potential of precision medicine. Our investigational trials are studying innovative therapeutic candidates with the potential to help patients with certain cancers live better, longer lives. ...
-
Manufactured by Rocket Pharmaceuticals, Inc.based in USA
Rocket’s Research and Discovery group in the Cranbury, New Jersey facility utilizes approximately 20,000 square feet of state-of-the-art laboratories for designing, optimizing and advancing candidate therapeutics to clinical stage ...
-
Manufactured by Invicro, LLCbased in USA
of radiopharmaceuticals requires a partner that has extensive scientific, regulatory and operational expertise. Working with a CRO that provides a complete solution ensures data is delivered in a timely manner to make a go/no-go decision on your imaging or therapeutic candidates. ...
-
Manufactured by Nexelisbased in USA
For R&D in Immunogenicity, Immuno-Oncology, and Cell and Gene Therapy. We have exceptional in vitro bioassay development services and support for early evaluation and screening of candidate therapeutics. Our highly experienced team will facilitate in silico immunogenicity assessment with epitope prediction to in vitro immunogenicity and ...
-
based in USA
Our lead product, Lomecel-B, consists of human allogeneic bone-marrow derived MSCs as the active ingredient. These cells undergo cultured-expansion using proprietary processes, and are then formulated, packaged and stored frozen (cryopreserved) until shortly before use. Fresh bone marrow is procured from established, licensed U.S.-based third-party tissue suppliers, which harvest the tissue from ...
-
based in USA
Our lead product, Lomecel-B, consists of human allogeneic bone-marrow derived MSCs as the active ingredient. These cells undergo cultured-expansion using proprietary processes, and are then formulated, packaged and stored frozen (cryopreserved) until shortly before use. Fresh bone marrow is procured from established, licensed U.S.-based third-party tissue suppliers, which harvest the tissue from ...
-
Manufactured by Orbit Discoverybased in UNITED KINGDOM
The Orbit Discovery Affinity Screening platform offers a proprietary technology enabling the construction of massive bead-based libraries with peptides displayed on their surface. Each bead carries a unique DNA sequence, which is translated into peptide using in vitro transcription translation (IVTT) performed in an emulsion (emIVTT). Each droplet of the emulsion acts as a micro-compartment ...
-
Manufactured by Newcells Biotech Limitedbased in UNITED KINGDOM
In vitro assessment of Fibroblast-to-Myofibroblast transition (FMT). Newcells offers a fast and reliable FMT assay service to evaluate the efficacy of anti-fibrotic compounds using high-content imaging. This customisable, high-throughput assay is well suited to compound screening for small molecules targeting lung fibrosis. Normal repair processes are defective in the fibrotic lung. Repetitive ...
-
Manufactured by Bio-Rad Laboratories, Inc. (Antibodies)based in USA
Reduce Lead Time for Antibody Generation: Assays supporting SARS-CoV-2 vaccine, therapeutic, and diagnostic test development must be robust, scalable, and transferable to laboratories worldwide. They need to be designed and validated rapidly, yet without compromising quality. We understand that critical antibody reagents for these vital ...
-
Manufactured by Dyadic International, Inc.based in USA
We are building an active pipeline of products for human health by applying our proprietary and patented C1 technology to develop vaccines and antibodies for infectious and other diseases. Vaccine Development: The C1 platform is ready for full commercialization opportunities in recombinant protein ...
-
Manufactured by XILIS, Inc.based in USA
Xilis’ rapid and scalable patient-derived MicroOrganoSphere (MOS) technology platform enhances precision medicine and pharmaceutical drug discovery and development. Compared to conventional patient-derived models, MOS provides faster, higher-throughput, and greater cost savings, as well as more predictive and accurate results. MOS can be used in large-scale pharmacogenomic studies that are ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you